Expertise in
6
conditions

Julien Pottecher

Strasbourg, FR 
Expertise in
6
conditions
Strasbourg, FR 

Overview

Julien Pottecher practices practicing medicine in Strasbourg, France.

Mr. Pottecher is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), COVID-19, Thrombectomy, and Lung Transplant.

He is actively involved in clinical research, co-authoring 158 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Strasbourg, France
Other Locations
Montpellier, France
Paris, France
Nancy, France
CHU de Besançon
Besancon, France
1 Avenue Molière 67098 Strasbourg Cedex, Moliere, 67098, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic : Prospective Multicenter Cohort Study
Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic : Prospective Multicenter Cohort Study
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Enrollment Status: Completed
Publish Date: May 22, 2026
Intervention Type: Combination product
Study Phase: Not Applicable
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Enrollment Status: Unknown
Publish Date: March 23, 2022
Intervention Type: Other
Study Phase: Not Applicable
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: the Prospective Randomized MUSIC-TCNV Trial.
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: the Prospective Randomized MUSIC-TCNV Trial.
Enrollment Status: Terminated
Publish Date: November 17, 2021
Intervention Type: Other
Study Phase: Not Applicable
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Enrollment Status: Completed
Publish Date: August 19, 2021
Intervention Type: Drug
Study Drug: Human Immunoglobulin
Study Phase: Phase 3
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Enrollment Status: Completed
Publish Date: June 29, 2020
Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study
Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study
Enrollment Status: Unknown
Publish Date: August 01, 2018
Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.
Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.
Enrollment Status: Terminated
Publish Date: February 22, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
View 7 Less Clinical Trials

158 Total Publications

Does the Initial Injury Type Predict the Subsequent Assault?
Does the Initial Injury Type Predict the Subsequent Assault?
Journal: JAMA network open
Published: June 17, 2026

Frequently Asked Questions about Julien Pottecher

Is Julien Pottecher a top-rated expert for Acute Respiratory Distress Syndrome (ARDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Julien Pottecher is classified as an Distinguished expert for Acute Respiratory Distress Syndrome (ARDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Julien Pottecher participate in research or clinical trials?

Yes. Julien Pottecher has published 158 articles and abstracts on conditions like Acute Respiratory Distress Syndrome (ARDS). You can view a list of Julien Pottecher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pottecher's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile